Mohamed Khettab

MD, MSc. Medical Oncologist. Réunion hospital, and University, France. #oncology #EuropeOutermost #equityaccess #innovation

[Gustave Roussy @GustaveRoussy]

🔹 Le Dr Gazzah présente l'étude de phase 1 évaluant le stx-721 chez des patients avec cancers bronchiques et insertion EGFR exon 20.

#ASCO25 #ASCO

[Yakup Ergün @dr_yakupergun]

Pancreatic cancer

💥Great review

(We could discuss the median OS of 4 months (?) mentioned in the first sentence)

https://t.co/8YS92bsraJ

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

New @JCO_ASCO📰| #Abemaciclib Plus #Fulvestrant in Advanced #BreastCancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial
🔓https://t.co/QAoSGNPDxh
✍️@KalinskyKevin @BianchiniGP @ErikaHamilton9
@DrSGraff @RMJesel @drsarahsam @MuozMateu
@bastien_nguyen #CDK

[Lurie Cancer Center @LurieCancer]

A fusion protein therapy may be an effective treatment option for cutaneous T-cell #lymphoma, according to a multicenter clinical trial published in @JCO_ASCO, co-authored by Timothy Kuzel, MD. https://t.co/F5pKfXBC6Q via @NUFeinbergMed #CTCL #lymsm

[HemOnc Today @HemOncToday]

Breast cancer survivors who harbor a BRCA gene mutation are at elevated risk for second primary cancers, according to data published in @JCO_ASCO. These individuals likely would benefit from enhanced surveillance and risk-reduction measures. #BreastCancer
https://t.co/aPfFkJ3KEZ

[Journal of Clinical Oncology @JCO_ASCO]

Germline and Somatic Genomic Testing for Metastatic
Prostate Cancer: ASCO Guideline ➡️ https://t.co/MgAnOtWjTg
#ProstateCancer #pcsm

[Julien Mazieres @JulienMazieres]

Early access to new drugs in #NSCLC in France. Nice overview by PJ Souquet. ⁦@IFCTlung⁩ translational meeting.

[OncoDaily IO @OncoDailyIO]

Chimeric Antigen Receptor-T Cells in Colorectal Cancer - @ShaidaOuladan
@JCO_ASCO

https://t.co/oqUTmtezFa

#Cancer #Crcsm #ImmuneOnc #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[Elisa Agostinetto @ElisaAgostinett]

🇮🇹@OncoAlert Colloquium si avvicina!
3-9 Febbraio, 100% virtuale, interattivo e completamente gratuito. Link per registraz ⬇️
🇧🇪🇫🇷@OncoAlert Colloquium s’approche!
Du 3 au 9 février, 100% virtuel, interactif et complètement gratuit
Lien pour s’inscrire⬇️
https://t.co/Qx8Zgmi6oN

[A.n.n. @fireflyann]

@OncoAlert

https://t.co/5no5TVem97

[IJGC @IJGConline]

Join us in welcoming Dr. Manel Montesinos-Albert, @MMontesinos_Alb, our new #EditorialFellow from Hospital La Fe in Valencia #Spain🇪🇸
Welcome aboard!💖

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
@thomasbartlMD @kfischermd @claritasantia @stephjeangill @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen
@RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada

#IJGConline #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

[Yüksel Ürün @DrYukselUrun]

Can mpMRI replace TURBT for faster treatment in MIBC?
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #BladderCancer #MRI #Oncology @ASCO @JCO_ASCO @OncoAlert @Prof_Nick_James @JimCatto
https://t.co/iNUqvfXiR4

[CURE Today @cure_today]

Fish Oil Diet May Reduce Ki-67 Biomarkers in #ProstateCancer. #FishOils @JCO_ASCO
https://t.co/g4chM2dlWo

[Andrea Necchi, MD, FASCO @AndreaNecchi]

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial | Journal of Clinical Oncology https://t.co/z87ZuNjwjw @JCO_ASCO @ASCO @Prof_Nick_James

[Dr Pratiek Paatil @Oncologist_Pune]

EMERALD trial ⁦@JCO_ASCO⁩ shows Eribulin non-inferior to Taxanes ! For Her2+ MBC.
In what setting would you wanna use it ? ⁦@OncBrothers⁩ ⁦@Larvol⁩ ⁦@MedscapeOnc⁩ ⁦⁦@FDAOncology⁩ ⁦@OncoAlert⁩ #oncology #medx #medtwitter

[Mohamed Khettab @M_Khettab]

Au nom de #UCOM, nous apportons tout le soutien nécessaire pour les patients et les soignants notamment en matière de cancérologie. UCOM mobilisé afin de prendre le relais pour patients de #Mayotte nécessitant des prises urgentes.@EmelineColomba @GroupeUnicancer

[soria @jsoriamd]

Fructose consumption has increased considerably over the past five decades, due to the widespread use of high-fructose corn syrup as a sweetener. A recent publication shows that fructose supplementation enhances tumor growth in various animal models. The liver converts dietary fructose to lipids that enter the blood, & cancer cells use the lipids to make membranes for proliferation.
https://t.co/l1LnG6aI12
https://t.co/XImObiNm8H

[Emeline COLOMBA @EmelineColomba]

Historique au niveau local : on l’a fait ! Une nouvelle filière des traitements des cancers mammaires et Gyneco a ouvert @CHUM972 . L’ équipe ONCOFANM a reçu la 1ere patiente le 14/11/24. Bravo 🎉 @ArsMartinique @DG_ARS_Mq @JLB56972 @FatihaNehal 👉🏾 https://t.co/eYfMfx0Jex

[Mohamed Khettab @M_Khettab]

Super projet. Bravo @EmelineColomba

[Lloyd Bod @Lloyd_Bod]

@EmelineColomba @CHUM972 @ArsMartinique @DG_ARS_Mq @JLB56972 @FatihaNehal Bravo!!! 🍾🎉🎊 vraiment admiratif de voir ONCOFANM se concrétiser!

[ARS La Réunion @ARS_LaReunion]

📊 Couverture vaccinale à La Réunion : des progrès, mais des efforts à poursuivre
✅ 9 enfants sur 10 de moins de 2 ans vaccinés pour 6 vaccins obligatoires.
Objectifs à atteindre 95 % :
•Pneumocoque : 86,8%
•ROR : 82%
•Méningocoque C : 49%
🔗 Détails : https://t.co/B8kHbzUH0E